|
SEC
|
Shannon James Samuel
|
N/A
|
|
+70K
|
$0.69
|
+$48.30K
|
|
|
SEC
|
Russo Rene
|
PRESIDENT AND CEO
|
|
+36K
|
$0.68
|
+$24.68K
|
|
|
SEC
|
GILEAD SCIENCES, INC.
|
N/A
|
|
+1.8M
|
$1.04
|
+$1.83M
|
|
|
SEC
|
GILEAD SCIENCES, INC.
|
N/A
|
|
+485K
|
$0.76
|
+$368.79K
|
|
|
SEC
|
Atlas Venture Associates Opportunity I, LLC
|
N/A
|
|
-1K
|
$0.64
|
-$640.00
|
|
|
SEC
|
Atlas Venture Associates Opportunity I, LLC
|
N/A
|
|
-4.2K
|
$0.85
|
-$3.60K
|
|
|
SEC
|
BCIP Life Sciences Associates, LP
|
N/A
|
|
+42K
|
$9.66
|
+$410.25K
|
|
|
SEC
|
Atlas Venture Opportunity Fund I, L.P.
|
N/A
|
|
+2.7M
|
$16.00
|
+$43.73M
|
|
|
SEC
|
BAY CITY CAPITAL LLC
|
N/A
|
|
+1.1M
|
$16.00
|
+$18.07M
|
|
|
SEC
|
Deerfield Mgmt V, L.P.
|
N/A
|
|
+775K
|
$16.00
|
+$12.40M
|
|
|
SEC
|
Four Pines Master Fund LP
|
N/A
|
|
+1.4M
|
$16.00
|
+$22.52M
|
|
|
SEC
|
RiverVest Venture Fund IV, L.P.
|
N/A
|
|
+1.4M
|
$16.00
|
+$23.06M
|
|
